Effects of Dietary Proteins on Hepatic Lipid Metabolism

NCT00558740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2012-02-10

No results posted yet for this study

Summary

Individuals submitted to a high-fat or a high-fructose/sucrose diet develop, over a 6 day-period, several features of the metabolic syndrome, including increased plasma triglycerides, increased intrahepatic lipids, and decreased hepatic insulin sensitivity. It has been recently observed that the increase in intrahepatic lipids observed after a high fat diet is largely prevented when protein intake is concomitantly increased. This suggests that dietary protein protects the liver against some of the deleterious effects of a high fat diet. Mechanisms underlying this effect of protein may include an increased hepatic fat oxidation.

The aims of this study are:

1. to evaluate the effects of dietary protein on several major pathways involved in hepatic lipid metabolism ( ketogenesis, lipid oxidation, de novo lipogenesis, VLDL-triglyceride secretion
2. to determine whether the decrease in intra-hepatic lipids observed when dietary protein intake is increased are to be attributed to acute or long-term effects of proteins

Conditions

  • Metabolic Syndrome X

Interventions

OTHER

high protein intake

acute high protein intake chronic (6-day) high protein intake acute+chronic high protein intake control

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER
  • University of Lausanne

    lead OTHER

Principal Investigators

  • l Tappy, MD · University of Lausanne

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00558740 on ClinicalTrials.gov